Logo-joddd

Visual Abstract

JODDD now with visual abstracts. Authors can now add a visual abstract to their submission.

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central.

  Indexing & Abstracting

Following


Social media

J Dent Res Dent Clin Dent Prospects. 2015;9(3): 166-174. doi: 10.15171/joddd.2015.031
PMID: 26697149        PMCID: PMC4682013

Original Research

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis

Naga Jyothi Meka 1 * , Sridevi Ugrappa 2, Nagalaxmi Velpula 3, Sravan Kumar 4, Kotya Naik Maloth 5, Srikanth Kodangal 6, Lalitha ch 7, Stuti Goyal 7

Cited by CrossRef: 12


1- Yang H, Zhang S, Wang J, Fan J, Qiao Y, Taylor P. Oral leukoplakia and the long‐term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population. Thorac Cancer. 2020;11(10):2804 [Crossref]
2- Singhi A, Arnold C, Lam-Himlin D, Nikiforova M, Voltaggio L, Canto M, McGrath K, Montgomery E. Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. Modern Pathology. 2017;30(11):1613 [Crossref]
3- Cai X, Zhang H, Li T. Multi-target pharmacological mechanisms of Salvia miltiorrhiza against oral submucous fibrosis: A network pharmacology approach. Archives of Oral Biology. 2021;126:105131 [Crossref]
4- Moorthy A, Venugopal D, Shyamsundar V, Madhavan Y, Ravindran S, Kuppuloganathan M, Krishnamurthy A, Sankarapandian S, Ganapathy V, Ramshankar V. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients—A Baseline Study. Diagnostics. 2022;12(8):1935 [Crossref]
5- Hou F, Yu Z, Cheng Y, Liu Y, Liang S, Zhang F. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations. Phytomedicine. 2022;103:154195 [Crossref]
6- Hashmi A, Hussain Z, Aijaz S, Irfan M, Khan E, Naz S, Faridi N, Khan A, Edhi M. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters. World J Surg Onc. 2018;16(1) [Crossref]
7- Pansini P, do Valle I, Damasceno T, de Abreu P, Có A, López R, Lenzi J, Rocha R, Souza E, Curado M, Mehanna H, Nankivell P, de Podestá J, von Zeidler S. Differential Expression of Potential Biomarkers of Oral Squamous Cell Carcinoma Development. Head and Neck Pathol. 2021;15(4):1127 [Crossref]
8- He C, Wang W, Wan W, Liang J, Hu J, Yuan Y, Jiang C, Li N. Tyrosine sulphation of CXCR4 induces the migration of fibroblast in OSF. Oral Diseases. 2022; [Crossref]
9- Hiraga C, Yamamoto S, Hashimoto S, Kasahara M, Minamisawa T, Matsumura S, Katakura A, Yajima Y, Nomura T, Shiba K. Pentapartite fractionation of particles in oral fluids by differential centrifugation. Sci Rep. 2021;11(1) [Crossref]
10- Ling Z, Cheng B, Tao X. Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities. Int J Cancer. 2021;148(7):1548 [Crossref]
11- Nikitakis N, Pentenero M, Georgaki M, Poh C, Peterson D, Edwards P, Lingen M, Sauk J. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018;125(6):650 [Crossref]
12- Condurache Hritcu O, Botez A, Olinici D, Onofrei P, Stoica L, Grecu V, Toader P, Gheucă‑solovăstru L, Cotrutz E. Molecular markers associated with potentially malignant oral lesions (Review). Exp Ther Med. 2021;22(2) [Crossref]